InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,427.89
(
-0.73%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

remind2

Send PM Follow Ignore
Followers 15
Posts 1647
Boards Moderated 0
Alias Born 05/15/2015

remind2

Re: None

Friday, 03/31/2017 1:23:35 PM

Friday, March 31, 2017 1:23:35 PM

Post# of 23979
GALT: Other NASH play BLRX @ .90s.

BioLineRX did a $25M secondary today that sent the stock to .90s.

The great move in GALT is a set-up for BLRX now that the secondary is out of the way and BLRX is flush.

Novartis is the BLRX partner on the NASH liver drug.

Link:
http://www.fiercebiotech.com/biotech/novartis-partner-biolinerx-licenses-nash-drug-after-joint-evaluation
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up